by Kristen Lomas | Mar 5, 2025 | Press Releases
Multicenter, randomized controlled pivotal study to investigate a novel device for post-radical prostatectomy stress urinary incontinence Durham, NC – March 4, 2025 – Levee Medical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted...
by Kristen Lomas | Feb 13, 2025 | Press Releases
Funding to Advance Voro® Urologic Scaffold Development and Clinical Studies Durham, NC – February 11, 2025 – Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, announced the successful close of its Series B...
by John Assalian | Jun 25, 2024 | Press Releases
Additionally, Company Reaches Significant Enrollment Milestones in Feasibility and Observational Studies Durham, NC – June 10, 2024 – Levee Medical®, a medical device company designing solutions to improve surgical outcomes following prostate cancer, announced today...
by waltz-admin | Sep 6, 2023 | Press Releases
Milestone Achieved as Company Announces Successful Enrollment of First Patients in its First-in-Human (FIH) Study DURHAM, NC – Sept. 6, 2023 – Levee Medical, a clinical-stage medical device company designing solutions to improve surgical outcomes following prostate...
by waltz-admin | Aug 23, 2022 | Press Releases
Company to Accelerate Development of Novel Urologic Device Designed to Improve Recovery Outcomes Post-Prostatectomy Durham, NC – August 23, 2022 – Levee Medical, a medical device company designing solutions to improve surgical outcomes following prostate cancer,...
